Kinfo
BioLineRx Ltd. Sponsored American Depositary Receipt logo

BioLineRx Ltd. Sponsored American Depositary Receipt

BLRXNASDAQHealthcare·US · USD
$2.75
+0.00 (+0.00%)
Prices as of August 10, 2026 · live

Price

Key statistics

Valuation
Market cap12.19M USD
Enterprise value7.67M USD
Trailing P/E0.00
Forward P/E-4.45
PEG ratio-4.45
Price / sales9.15
Price / book0.79
Profitability
Gross margin80.08%
Operating margin-629.77%
Profit margin80.51%
Return on assets-16.55%
Return on equity-46.72%
Income (TTM)
Revenue1.40M USD
Gross profit1.11M USD
EBITDA-10.75M USD
Net income-7.90M USD
Diluted EPS$0.00
Rev. growth (YoY)87.10%
Balance sheet
Total cash17.35M USD
Total debt9.07M USD
Debt / equity43.53
Current ratio1.58
Book value / share$3.60
Cash flow (TTM)
Operating cash flow-7.76M USD
Levered free cash flow-5.49M USD
Shares & price
Shares outstanding2.61B
Float4.16M
Held by institutions0.41%
Beta0.71
50-day MA$3.08
200-day MA$2.97
52-week high$4.56
52-week low$2.15
Dividends
Forward rate
$0.00
Yield
0.00%
Payout ratio
0.00%
Frequency
Unknown
Earnings (EPS)
DateEst.ActualSurprise2026-02-250.160.43+168.75%2025-11-070.600.69+15.00%2024-05-27-0.29-0.01+96.55%2024-03-26-8.80-3.58+59.32%
About BioLineRx Ltd. Sponsored American Depositary Receipt

BioLineRx Ltd. is a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics primarily targeting oncology and rare diseases. Founded in 2003 and headquartered in Modi'in, Israel, BioLineRx leverages a comprehensive drug development platform to advance early-stage therapies through clinical trials. Its product pipeline includes APHEXDA (motixafortide), a peptide undergoing various clinical trials for conditions such as sickle cell disease, pancreatic cancer, and multiple myeloma, as well as BL-5010, a non-surgical treatment for skin lesions. The company plays a significant role in the biotechnology sector by partnering with other drug developers to bring novel treatments from research into commercial availability, aiming to address unmet medical needs and improve patient outcomes.

Sector
Healthcare
Industry
Biotechnology
Employees
20
Headquarters
Hevel Modi'in, Israel

Frequently asked questions about BioLineRx Ltd. Sponsored American Depositary Receipt